Yu‐Tzu Tai
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Chromatin Remodeling and Cancer, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → Neuropilin Is a Semaphorin III Receptor(1997)1,177 cited
- → Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors(2010)1,004 cited
- → Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma(2001)904 cited
- → Heterogeneity of genomic evolution and mutational profiles in multiple myeloma(2014)895 cited
- → Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy(2000)858 cited
- → Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer(2009)787 cited
- → The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications(2003)702 cited
- → Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy(2011)580 cited
- → Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma(2014)472 cited
- → Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu(2007)470 cited